What does neointimal hyperplasia (NIH) result in?

• A. Decrease in intimal tissue
• B. Increase in the reproduction of intimal tissue
• C. Stable intimal tissue levels
• D. Decrease in smooth muscle cells

Answer: (B)

Neointimal hyperplasia (NIH) refers to the process in which smooth muscle cells and extracellular matrix components proliferate in the intimal layer of a blood vessel after an injury, such as that caused by stenting or vascular surgical procedures. This proliferation leads to an increase in the amount of intimal tissue, which can contribute to narrowing or blockage of the blood vessel over time.

In cases of NIH, smooth muscle cells migrate and proliferate in response to factors released during the healing process, resulting in a significant increase in intimal tissue. This increase can lead to adverse outcomes such as restenosis, where the treated blood vessel narrows again, potentially compromising blood flow. Understanding this process is critical for developing strategies to prevent such complications in vascular interventions.

The other options do not accurately reflect the nature of neointimal hyperplasia; for instance, a decrease in intimal tissue or stable intimal tissue levels would not capture the essence of what occurs during this process. Similarly, a decrease in smooth muscle cells contradicts the fundamental mechanism of hyperplasia, which is characterized by an increase in these cells.